Max Planck Innovation is responsible for technology transfer from the research institutes of the Max Planck Society, Germany's leading basic research organization.

We are partners of both science and industry:

We perform an important task: the transfer of basic research results into products, which contribute to the economic and social progress.

Technology offers

Novel target to suppress autoantibody generation MZB1

Our technologies are as varied as the Max Planck Institutes themselves

all Technology offers

Latest news

Max Planck Society grants license for protein analysis technique
ProteoPlex has exclusively licensed a technology from the Max Planck Institute for Biophysical ...

News alert

Do you want to receive our newsletter and press releases?
Subscribe here